advanced search
Hans Peter Manser
Consultant

Is this your profile?

About

Hans Peter Manser was Senior Director, Business Development, Commercial Operation at SHL Medical until March 2021. He was previously Chief Executive Officer at Weibel CDS, which was acquired by SHL in 2020.

Contributions

WEARABLES
LARGE-VOLUME WEARABLE DRUG DELIVERY: A VISION BECOMES REALITY
Hans Peter Manser, Christoph Egloff and Martin C King introduce LV DDS , a flexible-form, low-profile wearable injector platform, for large-volume drug delivery.

More contributions

PREFILLED SYRINGES
LYCAJECT: AUTOMATIC RECONSTITUTION PATCH INJECTOR
Hans Peter Manser, Christoph Egloff and Martin C King introduce the LyCaJect Patch Injector, Weibel CDS’ offering in the field of wearable injectors, with automatic reconstitution as a headline feature.
INJECTION
SUPERCAPSYRINGE® PASSES THE TEST
Hans Peter Manser, Lisa Lippuner and Sarah Raible discuss the findings of a study conducted to test the qualities of Weibel’s SuperCapSyringe®.
PREFILLED SYRINGES
DRUGDELIVERYSYSTEM FOR 1 ML LONG PREFILLED SYRINGES
Ludwig Weibel and Hans Peter Manser ask, how can drug delivery systems help in patient compliance? And what are the challenges to be encountered with novel drugs filled in 1 mL long prefilled syringes? A novel and innovative approach is presented meeting the requirements of today’s and future drug applications.
INJECTION
A CARTRIDGE-BASED DRUGDELIVERYSYSTEM FOR PUMP SYSTEMS
Ludwig Weibel describes small, easy-to-use cartridge-based drug delivery systems and discusses how Weibel's system incorporates all the parts needed for a specific drug application into one product.
INJECTION
DRUGDELIVERYSYSTEM: READY TO USE FOR HIGHEST PATIENT COMFORT
Ludwig Weibel and Hans Peter Manser discuss micro-infusion, a novel and innovative approach offering pharmaceutical companies, healthcare personnel and patients all numerous advantages.
INJECTION
RECONSTYRINGE®: FULL INTEGRATION OF ALL FUNCTIONS & PARTS, FULLY AUTOMATED RECONSTITUTION
Ludwig Weibel and Hans Peter Manser introduce the Reconstyringe® system, which offers a fully automated reconstitution of lyophilised drugs.
Top